Literature DB >> 32793692

Hitting the brakes on autophagy for overcoming acquired resistance in triple negative breast cancer.

Chiara Bellio1, Josep Villanueva1,2.   

Abstract

Entities:  

Year:  2020        PMID： 32793692      PMCID： PMC7396768          DOI： 10.21037/atm.2020.04.17

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  24 in total

1.  Anticancer autophagy inhibitors attract 'resurgent' interest.

Authors:  Elie Dolgin
Journal:  Nat Rev Drug Discov       Date:  2019-06       Impact factor: 84.694

Review 2.  Chemoresistance mechanisms of breast cancer and their countermeasures.

Authors:  Xiwei Ji; Yuan Lu; Huifang Tian; Xiangrui Meng; Minji Wei; William C Cho
Journal:  Biomed Pharmacother       Date:  2019-03-25       Impact factor: 6.529

3.  PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer.

Authors:  Vito W Rebecca; Michael C Nicastri; Colin Fennelly; Cynthia I Chude; Julie S Barber-Rotenberg; Amruta Ronghe; Quentin McAfee; Noel P McLaughlin; Gao Zhang; Aaron R Goldman; Rani Ojha; Shengfu Piao; Estela Noguera-Ortega; Alessandra Martorella; Gretchen M Alicea; Jennifer J Lee; Lynn M Schuchter; Xiaowei Xu; Meenhard Herlyn; Ronen Marmorstein; Phyllis A Gimotty; David W Speicher; Jeffrey D Winkler; Ravi K Amaravadi
Journal:  Cancer Discov       Date:  2018-11-15       Impact factor: 39.397

4.  Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers.

Authors:  Sylvain Lefort; Carine Joffre; Yann Kieffer; Anne-Marie Givel; Brigitte Bourachot; Giulia Zago; Ivan Bieche; Thierry Dubois; Didier Meseure; Anne Vincent-Salomon; Jacques Camonis; Fatima Mechta-Grigoriou
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

5.  Elongation factor-2 kinase: its role in protein synthesis and autophagy.

Authors:  William N Hait; Hao Wu; Shenkan Jin; Jin-Ming Yang
Journal:  Autophagy       Date:  2006-10-03       Impact factor: 16.016

Review 6.  The dynamic nature of autophagy in cancer.

Authors:  Alec C Kimmelman
Journal:  Genes Dev       Date:  2011-10-01       Impact factor: 11.361

Review 7.  Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases.

Authors:  Rui Liu; Christopher G Proud
Journal:  Acta Pharmacol Sin       Date:  2016-01-25       Impact factor: 6.150

Review 8.  Current approaches in treatment of triple-negative breast cancer.

Authors:  Hanan Ahmed Wahba; Hend Ahmed El-Hadaad
Journal:  Cancer Biol Med       Date:  2015-06       Impact factor: 4.248

Review 9.  Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge.

Authors:  Milica Nedeljković; Ana Damjanović
Journal:  Cells       Date:  2019-08-22       Impact factor: 6.600

10.  eEF2 kinase mediated autophagy as a potential therapeutic target for paclitaxel-resistant triple-negative breast cancer.

Authors:  Ruo-Xi Wang; Xiao-En Xu; Liang Huang; Sheng Chen; Zhi-Ming Shao
Journal:  Ann Transl Med       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.